Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis

Guardat en:
Dades bibliogràfiques
Publicat a:Addiction Science & Clinical Practice vol. 20 (2025), p. 1
Autor principal: Ti, Lianping
Altres autors: Mihic, Tamara, Beauchesne, Arielle, Cameron, Grant, Frank, Ingrid, Haji, Nooreen, Legal, Michael, Shalansky, Stephen, Nolan, Seonaid
Publicat:
Springer Nature B.V.
Matèries:
Accés en línia:Citation/Abstract
Full Text
Full Text - PDF
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

MARC

LEADER 00000nab a2200000uu 4500
001 3216563944
003 UK-CbPIL
022 |a 1940-0632 
022 |a 1940-0640 
022 |a 1930-4307 
022 |a 1930-4315 
024 7 |a 10.1186/s13722-025-00574-x  |2 doi 
035 |a 3216563944 
045 2 |b d20250101  |b d20251231 
084 |a 264929  |2 nlm 
100 1 |a Ti, Lianping 
245 1 |a Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis 
260 |b Springer Nature B.V.  |c 2025 
513 |a Journal Article 
520 3 |a BackgroundHigh-risk opioid prescribing (e.g., high daily dose opioids, concurrent opioid-sedatives) is prevalent in hospitals and linked to adverse outcomes. Opioid stewardship programs (OSP) have the potential to reduce high-risk opioid prescribing through audit-and-feedback recommendations.MethodsWe evaluated an audit-and-feedback based OSP implemented in January 2020 at a Vancouver, Canada tertiary care hospital using interrupted time series analysis. An electronic health record (EHR) system with computerized provider order entry (CPOE) was simultaneously operationalized. The main outcome was: any high-risk opioid prescribing (based on 10 evidence-based indicators), including high daily dose of morphine milligram equivalent (MME) prescribing (> 90MME), long opioid prescription duration (> 5 days post-admission), and concurrent opioid-sedative prescribing.ResultsBetween January 2018 and March 2022, 5,477 active opioid patient encounters were included. While no significant change occurred in overall high-risk opioid prescribing post-OSP (p > 0.05), a significant reduction was seen in the level of high daily dose of MME prescriptions (estimate: -0.044; 95% confidence interval [CI]: -0.082, -0.006). Conversely, the trend in long opioid duration increased (estimate: 0.006; 95%CI: 0.000, 0.011), likely due to the removal of automatic stop dates with the implementation of the EHR with CPOE. Post-OSP intervention, we initially saw an acute increase in concurrent opioid-sedative prescriptions (estimate: 0.013; 95%CI: 0.005, 0.020). A benzodiazepine ordering intervention implemented in May 2021 reversed this trend, reducing both the level (estimate: 0.874; 95%CI: 0.374, 1.375) and slope (estimate: -0.022, 95%CI: -0.034, -0.011) of concurrent prescriptions.ConclusionThe implementation of a new EHR concordant with that of the OSP may have impacted our study’s results. While our research suggests the OSP reduced high-dose opioid prescribing, other indicators impacted by the EHR system did not benefit as highly from the OSP. Nevertheless, the OSP proved able to rapidly respond to unintended consequences by introducing interventions to reduce concurrent opioid and sedative prescribing. 
651 4 |a United States--US 
653 |a Prescriptions 
653 |a Risk reduction 
653 |a Emergency medical care 
653 |a Intervention 
653 |a Pain management 
653 |a Sedative drugs 
653 |a Time series 
653 |a Opioids 
653 |a Prescribing 
653 |a Drug stores 
653 |a Anesthesia 
653 |a Benzodiazepines 
653 |a Learning activities 
653 |a Feedback 
653 |a Prescription drugs 
653 |a Drug dosages 
653 |a Narcotics 
653 |a Clinical practice guidelines 
653 |a Electronic health records 
653 |a Patient safety 
653 |a Medicine 
653 |a Addictions 
653 |a Audits 
653 |a Hospitals 
653 |a High risk 
653 |a Palliative care 
653 |a Morphine 
653 |a Computerization 
653 |a Hospitalization 
653 |a Critical care 
653 |a Management 
653 |a Medical records 
653 |a Risk 
653 |a Tranquilizing drugs 
653 |a Health services 
653 |a Sedatives 
700 1 |a Mihic, Tamara 
700 1 |a Beauchesne, Arielle 
700 1 |a Cameron, Grant 
700 1 |a Frank, Ingrid 
700 1 |a Haji, Nooreen 
700 1 |a Legal, Michael 
700 1 |a Shalansky, Stephen 
700 1 |a Nolan, Seonaid 
773 0 |t Addiction Science & Clinical Practice  |g vol. 20 (2025), p. 1 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3216563944/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3216563944/fulltext/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3216563944/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch